Maharashtra Reports 23 Omicron Cases

Maharashtra has reported the highest spike of Omicron cases, 23, so far, taking the tally to 88, said health officials.

Of the new cases, 18 are fully vaccinated, one not inoculated and four are minors, and comprise 13 from Pune, five from Mumbai, 2 each from Thane and Osmanabad, and one from Nagpur.

Omicron is 3 Times More Transmissible Than Delta Variant
Omicron is three times more transmissible that the Delta variant. Union Health Ministry asked the states to focus on Covid Appropriate Behavior as strategic areas of intervention.

‘Among the new cases, 16 had a travel history, including 6 to UAE, 4 to Europe, 2 each to Ghana and South Africa, besides one each to Singapore and Tanzania, while the other 7 are the close contacts of these Omicron infectees.’

Tweet it Now

While 17 patients are asymptomatic, 6 have exhibited mild symptoms and they span the age group from below 18 to 60-plus.

Intensive surveillance of passengers arriving at the three international airports - Mumbai, Pune and Nagpur - is currently underway since December 1.

A total of 22,859 travelers have landed here from the "high risk" countries of which 117 have tested positive and 39 from other countries, with all their reports sent for genomic sequencing to confirm if they are afflicted by Omicron.

Omicron Variant Cases Doubling in 3 Days, Says WHO
Omicron variant of COVID-19 has now spread to about 89 countries, said the World Health Organization (WHO). Omicron is a highly divergent variant with a high number of mutations.

Besides, 670 samples from field surveys conducted since November 1 have been sent for genomic sequencing with the results of 124 awaited, said Health Department officials.

The current spread of Omicron is extensive in the state, with 35 cases each in Mumbai and Pune, five each in Osmanabad and Thane, three in Satara, two in Nagpur, and one each in Palghar, Latur, and Buldhana.

Sputnik V Covid Vaccine Effective Against Omicron Variant
Sputnik V covid vaccine is effective against the vaccine-evading and super mutant Omicron variant of Covid.

Source-IANS

COVID-19: Oxford-AstraZeneca Begins Work on Omicron-Targeted Vaccine
The pharma giant AstraZeneca and Oxford University have come together to develop a COVID-19 vaccine that specifically targets the Omicron variant.